Investor webcast to be held on Monday November 3, 2025 at 8:00 am EST
Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy
Seeking Alpha / 3 hours ago 3 Views
Investor webcast to be held on Monday November 3, 2025 at 8:00 am EST
Comments